GO:0002523 leukocyte migration involved in inflammatory response: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002523 describes the directed movement of leukocytes within or between tissues as part of an inflammatory response.
• Leukocyte migration is a multistep cascade: capture, rolling, activation, adhesion, and transendothelial migration.
• Chemokines and their receptors provide spatial and temporal cues that fine-tune leukocyte recruitment.
• The process is highly plastic, with leukocytes adapting their migratory modes during haematopoiesis and inflammation.
• Dysregulated leukocyte migration contributes to chronic inflammatory diseases, tissue damage, and cancer progression [1,5].
• Experimental models include knockout, knock-in, and overexpression cell lines, plus proteomic and imaging approaches [3,6].
Description
Leukocyte migration involved in inflammatory response (GO:0002523) is a biological process defined as the movement of a leukocyte within or between different tissues and organs of the body contributing to an inflammatory response. This process is fundamental to innate and adaptive immunity, enabling neutrophils, monocytes, lymphocytes, and other leukocytes to reach sites of infection or injury. The migration is not random; it is orchestrated by a series of molecular interactions between leukocytes and endothelial cells, guided by chemokines and adhesion molecules. Understanding GO:0002523 is critical for researchers studying inflammation, host defense, and diseases characterized by aberrant immune cell trafficking, such as atherosclerosis, rheumatoid arthritis, and cancer [1,5]. Recent studies highlight the plasticity of leukocyte migration, showing that cells can switch between amoeboid and mesenchymal modes depending on the tissue microenvironment. This plasticity ensures effective immune surveillance but can also contribute to pathological conditions when deregulated. The term encompasses both the movement of leukocytes within tissues and their transmigration across endothelial barriers, making it a central node in inflammatory biology.
leukocyte migration involved in inflammatory response At A Glance
| GO ID | GO:0002523 |
|---|---|
| GO term | leukocyte migration involved in inflammatory response |
| Ontology | biological_process |
| Synonym | immune cell migration during inflammatory response; leukocyte trafficking during inflammatory response; leucocyte migration during inflammatory response |
| Major function | Coordinated movement of leukocytes to sites of inflammation |
| Key cellular players | Neutrophils, monocytes, lymphocytes, endothelial cells |
| Molecular cues | Chemokines, integrins, selectins, adhesion molecules |
| Physiological outcome | Immune cell recruitment and initiation of inflammatory response |
What Is GO:0002523?
GO:0002523, leukocyte migration involved in inflammatory response, refers to the directed movement of leukocytes within or between different tissues and organs of the body as part of an inflammatory response. This includes the coordinated series of adhesive and signaling events that allow leukocytes to exit the bloodstream, navigate through the extracellular matrix, and reach inflammatory foci [1,8].
Why Is leukocyte migration involved in inflammatory response Important in Cell Biology?
Leukocyte migration involved in inflammatory response is essential for host defense, but its dysregulation underlies a wide range of human diseases. The process determines how quickly and effectively immune cells reach injured or infected tissues, and it shapes the resolution or chronicity of inflammation. Because leukocyte trafficking is a hallmark of inflammatory diseases and cancer, it represents a major target for therapeutic intervention [5,7].
• Enables rapid neutrophil recruitment to sites of infection, critical for bacterial clearance.
• Facilitates monocyte and lymphocyte infiltration into inflamed tissues, driving adaptive immunity.
• Dysregulated migration contributes to chronic inflammatory diseases such as arthritis and atherosclerosis.
• Tumor-infiltrating leukocytes, including regulatory T cells, can promote cancer progression and poor prognosis.
• Chemokine synergy fine-tunes the inflammatory response, affecting migration efficiency and specificity.
• Leukocyte migration is plastic, allowing cells to adapt to different tissue environments.
• Sphingolipids regulate leukocyte biology and inflammatory responses, impacting migration.
• Proteomic studies have identified key proteins in leukocyte transendothelial migration during inflammation.
• Understanding this process aids in developing anti-inflammatory therapies and cancer immunotherapies [1,5].
What Happens During leukocyte migration involved in inflammatory response?
Capture and Rolling
In simple terms: Leukocytes first slow down and roll along the blood vessel wall.
The initial step of leukocyte migration involves transient interactions between selectins on endothelial cells and their ligands on leukocytes, causing the cells to tether and roll along the vessel wall. This rolling is a prerequisite for subsequent firm adhesion and is mediated by P-selectin and E-selectin on activated endothelium. Chemokines presented on the endothelial surface can also trigger inside-out signaling to activate integrins during this phase.
Activation and Firm Adhesion
In simple terms: Chemokines activate the leukocyte, causing it to stick tightly to the vessel wall.
Chemokines such as CXCL8 and CCL2 bind to G-protein-coupled receptors on leukocytes, triggering intracellular signaling that activates integrins (e.g., LFA-1 and VLA-4). This activation leads to conformational changes in integrins, enabling high-affinity binding to endothelial ligands like ICAM-1 and VCAM-1, resulting in firm adhesion. This step is critical for arresting leukocytes at the correct location.
Transendothelial Migration
In simple terms: The leukocyte squeezes through the endothelial cell layer into the tissue.
After firm adhesion, leukocytes undergo transendothelial migration, moving through endothelial cell junctions or directly through the cell body (transcellular route). This process involves coordinated interactions between leukocyte integrins and endothelial junctional molecules such as PECAM-1 and CD99. Proteomic analyses have identified numerous proteins involved in leukocyte transendothelial migration during inflammatory conditions.
Migration Within Tissues
In simple terms: Once inside the tissue, leukocytes crawl toward the source of inflammation.
Within tissues, leukocytes navigate along chemokine gradients and through extracellular matrix using integrins and other adhesion receptors. They can adopt different migration modes, including amoeboid and mesenchymal, depending on the tissue environment. This plasticity allows efficient navigation through diverse tissues such as the liver, where neutrophils exhibit unique migratory behaviors.
Resolution and Plasticity
In simple terms: Leukocytes can change their migration style and eventually the response resolves.
Leukocyte migration is not a fixed program; cells can switch between migration modes and even reverse migration back into the vasculature. Resolution of inflammation involves cessation of recruitment and clearance of leukocytes. Sphingolipids and other lipid mediators play roles in regulating these processes.
Key Genes Involved in GO:0002523 leukocyte migration involved in inflammatory response
The following genes and proteins are key players in leukocyte migration involved in inflammatory response, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGAL (LFA-1) | Integrin mediating firm adhesion to ICAM-1 | Target for anti-inflammatory therapies |
| ITGB2 (CD18) | Integrin beta chain partnering with LFA-1 | Defects cause leukocyte adhesion deficiency |
| ICAM1 | Endothelial ligand for LFA-1 | Upregulated in inflammation, promotes adhesion |
| VCAM1 | Endothelial ligand for VLA-4 | Mediates monocyte and lymphocyte adhesion |
| SELE (E-selectin) | Endothelial selectin for rolling | Expressed on activated endothelium |
| SELP (P-selectin) | Endothelial/platelet selectin for rolling | Stored in Weibel-Palade bodies |
| CXCL8 (IL-8) | Chemokine activating neutrophils | Drives neutrophil recruitment |
| CCL2 (MCP-1) | Chemokine recruiting monocytes | Key in chronic inflammation |
| CXCR2 | Chemokine receptor on neutrophils | Mediates activation and adhesion |
| CCR2 | Chemokine receptor on monocytes | Promotes monocyte migration |
| PECAM1 (CD31) | Junctional molecule for transmigration | Facilitates leukocyte passage |
| CD99 | Junctional molecule for transmigration | Regulates transendothelial migration |
| SPHK1 | Sphingosine kinase 1, produces S1P | Regulates leukocyte trafficking |
| S1PR1 | Sphingosine-1-phosphate receptor 1 | Controls lymphocyte egress |
| FOXP3 | Regulatory T cell transcription factor | Tumor-infiltrating Tregs drive poor prognosis |
| MMP9 | Matrix metalloproteinase for matrix degradation | Facilitates tissue invasion |
| RAC1 | Rho GTPase regulating actin dynamics | Controls migratory mode |
How Is leukocyte migration involved in inflammatory response Regulated?
Leukocyte migration involved in inflammatory response is tightly regulated at multiple levels. Chemokine gradients and their receptor expression determine directionality and specificity. Integrin affinity is dynamically modulated by inside-out signaling, allowing rapid switching between adhesive and migratory states. Sphingolipid metabolism, particularly the balance between sphingosine-1-phosphate and ceramide, regulates leukocyte egress and trafficking. Plasticity in migration modes is controlled by Rho GTPases such as RAC1 and RHOA, which respond to environmental cues. Additionally, proteomic studies have revealed that proteins involved in inflammatory response and leukocyte transendothelial migration are differentially regulated during early lung blast injury.
leukocyte migration involved in inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITGB2 | Leukocyte adhesion deficiency | Knockout cell line (e.g., HL-60) |
| CCR2 | Atherosclerosis, chronic inflammation | Knockout mice or monocyte cell lines |
| FOXP3 | Hepatocellular carcinoma | Overexpression in Treg cell lines |
| SPHK1 | Inflammatory diseases, cancer | Knockout or knock-in in leukocyte cell lines |
| MMP9 | Liver inflammation | Knockout in neutrophil-like cells |
Chronic Inflammatory Diseases
Dysregulated leukocyte migration is a hallmark of chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis. Excessive recruitment of neutrophils and monocytes leads to tissue damage and perpetuates inflammation. Targeting chemokine receptors or integrins has shown therapeutic potential in preclinical models.
Cancer and Tumor Microenvironment
Leukocyte migration into tumors shapes the immune microenvironment. Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in hepatocellular carcinoma. Understanding how leukocytes migrate into tumors can inform immunotherapeutic strategies.
Liver Inflammation and Injury
Neutrophils exhibit unique migratory behaviors within the hepatic environment, contributing to liver inflammation and injury. Proteomic analysis of early lung blast injury revealed key proteins involved in leukocyte transendothelial migration, suggesting similar mechanisms in other organs.
From leukocyte migration involved in inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate leukocyte adhesion? | Knockout of gene X in HL-60 or Jurkat cells |
| Does a point mutation in ITGB2 affect integrin activation? | Point mutation knock-in in leukocyte cell lines |
| Does overexpression of CCR2 enhance monocyte migration? | Overexpression in monocytic cell lines |
| Does tagging of PECAM1 affect its localization? | Tagged knock-in in endothelial cells |
| Does FOXP3 overexpression alter Treg migration? | Overexpression in primary T cells or cell lines |
| Does knockout of SPHK1 affect S1P-mediated migration? | Knockout in leukocyte cell lines |
How to Study the leukocyte migration involved in inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Proteomics | Protein abundance and modifications | Identify key proteins in leukocyte migration |
| Intravital microscopy | Real-time leukocyte movement in vivo | Study rolling and adhesion in live animals |
| Flow cytometry | Integrin activation and receptor expression | Assess leukocyte activation states |
| Adhesion assay | Leukocyte-endothelial binding | Test integrin function under flow |
| CRISPR screen | Genes regulating migration | Discover novel regulators |
| RNA-seq | Transcriptional changes during inflammation | Identify upregulated migration genes |
| Bioinformatics | Pathway and network analysis | Integrate omics data for migration pathways |
Proteomic Analysis
Proteomic approaches have been used to identify key proteins involved in inflammatory response, leukocyte transendothelial migration, and phagocytosis during early lung blast injury. Mass spectrometry-based proteomics can quantify changes in protein abundance and post-translational modifications in leukocytes under inflammatory conditions.
Imaging and Live-Cell Tracking
Intravital microscopy and live-cell imaging allow real-time visualization of leukocyte migration in tissues. These techniques reveal dynamic behaviors such as rolling, adhesion, and transmigration, and can be combined with fluorescent reporters for specific genes.
Flow Cytometry and Adhesion Assays
Flow cytometry can assess integrin activation states and chemokine receptor expression on leukocytes. Static and flow-based adhesion assays measure leukocyte binding to endothelial ligands under physiological shear stress.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR screens can identify genes that regulate leukocyte migration. Bioinformatics analysis of transcriptomic and proteomic data can reveal pathways and networks involved in inflammatory migration.
How CRISPR Can Be Used to Study GO:0002523 leukocyte migration involved in inflammatory response
Knockout
CRISPR knockout of genes such as ITGB2 or CCR2 in leukocyte cell lines can abolish specific migration steps, allowing researchers to test causality. Knockout models are essential for validating targets identified in screens.
Point Mutation
Point mutations in integrin genes (e.g., ITGB2) can mimic human leukocyte adhesion deficiency and reveal structure-function relationships. CRISPR point mutation knock-in enables precise modeling of disease-associated variants.
Knock-in
Knock-in of tagged versions of genes like PECAM1 or CD99 allows visualization and tracking of proteins during transendothelial migration. This approach is valuable for studying protein localization and dynamics.
Overexpression
Overexpression of chemokine receptors such as CCR2 or FOXP3 can enhance or alter migratory behavior, providing gain-of-function models [5,7]. These models help dissect the contribution of individual genes to leukocyte trafficking.
How EDITGENE Supports leukocyte migration involved in inflammatory response Research
Researchers studying leukocyte migration involved in inflammatory response-related genes often need to determine whether a candidate gene is causally involved in migration, adhesion, or transmigration. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for leukocyte migration involved in inflammatory response research.
Frequently Asked Questions About leukocyte migration involved in inflammatory response
What is GO:0002523?
GO:0002523 is the Gene Ontology term for leukocyte migration involved in inflammatory response, defined as the movement of a leukocyte within or between different tissues and organs of the body contributing to an inflammatory response.
What genes are involved in leukocyte migration involved in inflammatory response?
Key genes include ITGAL, ITGB2, ICAM1, VCAM1, SELE, SELP, CXCL8, CCL2, CXCR2, CCR2, PECAM1, CD99, SPHK1, S1PR1, FOXP3, MMP9, and RAC1 [4,5,6,7,8].
How does leukocyte migration contribute to inflammation?
Leukocyte migration brings immune cells to sites of infection or injury, where they release cytokines and mediators that drive the inflammatory response.
What are the steps of leukocyte migration?
The main steps are capture and rolling, activation and firm adhesion, transendothelial migration, and migration within tissues.
Which diseases are associated with abnormal leukocyte migration?
Chronic inflammatory diseases, cancer, and liver inflammation are associated with dysregulated leukocyte migration [1,5,6].
What methods are used to study leukocyte migration?
Proteomics, intravital microscopy, flow cytometry, adhesion assays, CRISPR screens, and bioinformatics are commonly used [1,2,3,8].
How can CRISPR be used to study leukocyte migration?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes involved in migration [2,8].
What is the role of chemokines in leukocyte migration?
Chemokines activate leukocytes and guide their movement along gradients to inflammatory sites.
What is leukocyte transendothelial migration?
It is the process by which leukocytes cross the endothelial cell layer to enter tissues, involving molecules like PECAM1 and CD99.
Why is leukocyte migration plasticity important?
Plasticity allows leukocytes to adapt their migration mode to different tissue environments, ensuring effective immune surveillance.
Conclusion
GO:0002523 leukocyte migration involved in inflammatory response is a central biological process that orchestrates immune cell recruitment during inflammation. Its molecular mechanisms, key genes, and regulatory pathways are well-studied, and its dysregulation contributes to numerous diseases. Advances in CRISPR models and omics technologies continue to unravel the complexities of leukocyte trafficking, offering new therapeutic opportunities. EDITGENE supports researchers in this field with tailored CRISPR services to accelerate discovery.
References
- 1. Nourshargh S et al.. 2014. Leukocyte migration into inflamed tissues.. Immunity 41(5):694-707 PMID: 25517612
- 2. Villella C et al.. 2025. Plasticity in leukocyte migration during haematopoiesis and inflammation.. J Muscle Res Cell Motil 46(2):135-151 PMID: 39964620
- 3. Liu Y et al.. 2021. Proteomic Analysis Revealed the Characteristics of Key Proteins Involved in the Regulation of Inflammatory Response, Leukocyte Transendothelial Migration, Phagocytosis, and Immune Process during Early Lung Blast Injury.. Oxid Med Cell Longev 2021:8899274 PMID: 34007409
- 4. Chiricozzi E et al.. 2018. Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection.. J Leukoc Biol 103(3):445-456 PMID: 29345379
- 5. Huang CH et al.. 2026. Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC.. Hepatology 83(6):1398-1415 PMID: 40590861
- 6. Alvarenga DM et al.. 2018. Neutrophil biology within hepatic environment.. Cell Tissue Res 371(3):589-598 PMID: 29127519
- 7. Gouwy M et al.. 2012. Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response.. Immunol Lett 145(1-2):10-4 PMID: 22698178
- 8. Muller WA. 2003. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.. Trends Immunol 24(6):327-34 PMID: 12810109
